Veinway
PrivateLast Round
SAFE
Sep 7, 2023
Total Funding Raised
$2.54M
Momentum Score
25 /100
Company Overview
Veinway is a therapeutic devices company developing a venous occlusion recanalization device for treating patients with deep vein thrombosis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Veinway Comps
Public and private peers based on sector, stage, and business model.
Veinway Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| SAFE | Sep 7, 2023 | ||||
| Series A | Sep 7, 2023 | ||||
| Seed | Nov 23, 2021 | ||||
| Grant | Dec 3, 2020 |
Veinway Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Grant, Seed |
| Consensus Business Group | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Monthly visitors grew 313% MoM, from 370 to 1.5K.
Veinway Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Veinway's valuation, stock price, and market status.
